静脉血栓患者吃拜瑞妥要吃多久？

(Rivaroxaban) is a highly selective, oral drug that directly inhibits factor Xa. By inhibiting factor Clinical studies have shown that Xarelto (rivaroxaban) can effectively prevent deep vein thrombosis after peri-hip fracture surgery. It has good safety and is worthy of clinical promotion. Today we will learn more about how long patients with venous thrombosis should take Xarelto?

The recommended dose of Xarelto (rivaroxaban) is 10 mg of Xarelto taken orally once daily. If the wound has stopped bleeding, the medication should be administered between 6-10 hours after surgery. The length of treatment is determined by each patient's risk of VTE, i.e. by the type of orthopedic surgery the patient has undergone.   For patients undergoing major hip surgery, a recommended course of treatment is 5 weeks. For patients undergoing major knee surgery, a recommended course of treatment is 2 weeks. If a dose is missed, the patient should take Xarelto immediately and continue taking the medication once a day the next day. Patients can take Xarelto with a meal or alone.

Xarelto (rivaroxaban) contraindications: Patients who are allergic to Xarelto or any excipients in the tablets; patients with clinically significant active bleeding; patients with liver disease with coagulation abnormalities and clinically relevant bleeding risks; pregnant and lactating women.

In terms of safety, domestic research statistics on bleeding complications after using Xarelto show no increase in fatal bleeding and intracranial bleeding. Bleeding complications such as urinary tract bleeding and hemorrhoid bleeding all have possible causes and the bleeding stops after treatment. Therefore, oral Xarelto anticoagulation is safer. Oral Xarelto does not require routine monitoring, and the anti-Factor Xa chromogenic test can be used to quantitatively determine plasma concentrations of Factor Xa inhibitors when bleeding induced by Xarelto is suspected.

Since Xarelto (rivaroxaban) cannot directly act on already produced thrombin, physiological hemostasis is less affected by it. The peak plasma concentration can be reached 2 to 4 hours after patients take this drug orally. It has the characteristics of strong anticoagulation such as rapid onset of action and rapid metabolism, and does not require monitoring of coagulation function. in the country, this drug was first approved for the prevention and treatment of venous thromboembolic disease. As people's understanding of it deepens, this drug is more and more widely used in clinical treatment.

The above is the content of how to take Rivaroxaban. I hope it can help you!

Recommended related hot articles: /newsDetail/76585.html